Showing results (1661-1670 of 2,601) with videos related to
Sort By:
Pageof 261
Endocrine-Related Cancer|July 28, 2011
Hepatic arterial infusion enhances DOTATOC radiopeptide therapy in patients with neuroendocrine liver metastasesClemens Kratochwil, Ruben López-Benítez, Walter Mier, et al.Journal of Hypertension|October 3, 2002
Variable day/night bias in 24-h non-invasive finger pressure against intrabrachial artery pressure is removed by waveform filtering and level correctionBerend E Westerhof, Ilja Guelen, Gianfranco Parati, et al.Plos One|August 23, 2012
GABA(A) receptor α subunits differentially contribute to diazepam tolerance after chronic treatmentChristiaan H Vinkers, Ruud van Oorschot, Elsebet Ø Nielsen, et al.Nederlands Tijdschrift Voor Geneeskunde|August 24, 2012
[Summarisation of the NHG practice guideline 'Anxiety']Mariëlle J P van Avendonk, Lieke J A Hassink-Franke, Berend Terluin, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|August 19, 2005
Effects of chronic treatment with fluvoxamine and paroxetine during adolescence on serotonin-related behavior in adult male ratsTrynke R de Jong, Liselore J A E Snaphaan, Tommy Pattij, et al.European Journal of Pharmacology|February 17, 2005
Citalopram combined with WAY 100635 inhibits ejaculation and ejaculation-related Fos immunoreactivityTrynke R de Jong, Tommy Pattij, Jan G Veening, et al.Brain Research|January 21, 2006
Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brainAniko Korosi, Jan G Veening, Tamás Kozicz, et al.Brain : a Journal of Neurology|November 26, 2013
Disrupted brain network topology in Parkinson's disease: a longitudinal magnetoencephalography studyKim T E Olde Dubbelink, Arjan Hillebrand, Diederick Stoffers, et al.Psychopharmacology|December 10, 2009
Increased cortical inhibition deficits in first-episode schizophrenia with comorbid cannabis abuseThomas Wobrock, Alkomiet Hasan, Berend Malchow, et al.Physics and Imaging in Radiation Oncology|July 18, 2022
Magnetic resonance imaging-guided radiotherapy for intermediate- and high-risk prostate cancer: Trade-off between planning target volume margin and online plan adaptionShyama U Tetar, Anna M E Bruynzeel, Lisa Verweij, et al.Pageof 261